[Therapy with LHRH analogs in a 41-year-old patient with metastatic breast cancer].
Hartmann
A
A
Medizinische Klinik II, Ludwig-Maximilians-Universität München.
Mann
K
K
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary*; D000328:Adult; D001943:Breast Neoplasms / Q000188:drug therapy*; D002064:Buserelin / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D003534:Cyproterone / Q000008:administration & dosage / Q000031:analogs & derivatives; D017373:Cyproterone Acetate; D005266:Femoral Neoplasms / Q000188:drug therapy / Q000556:secondary*; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D013629:Tamoxifen / Q000008:administration & dosage; D017329:Triptorelin Pamoate
D017329:Triptorelin Pamoate; D013629:Tamoxifen; D007987:Gonadotropin-Releasing Hormone; D017373:Cyproterone Acetate; D003534:Cyproterone; D002064:Buserelin
Therapie mit LHRH-Analoga bei einem 41jährigen Patienten mit metastasierendem Mammakarzinom.